Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer (Q40506711)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2004

Language	Label	Description	Also known as
English	Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer	scientific article published in September 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Hiroyuki Achiwa

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Tetsuya Oguri

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Shigeki Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hiroyoshi Maeda

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Takashi Niimi

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ryuzo Ueda

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

753-757

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Nucleoside transport in normal and neoplastic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Nucleoside and nucleobase transport systems of mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Nucleoside transporters: molecular biology and implications for therapeutic development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Potential mechanisms of resistance to cytarabine in AML patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

In vitro leukemia cell models of Ara-C resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03257.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2004.TB03257.X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40506711&oldid=1899455112"